Menu

Recent Interviews

Heye Daun, President and CEO, Osino Resources Corp.

Heye Daun
President and CEO | Osino Resources Corp.
Suite 810 – 789 West Pender Street, V6C 1H2 Vancouver (CAN)

jbecker@osinoresources.com

Interview Osino Resources: "The market has not yet realized how fast we are advancing Twin Hills."


Bradley Rourke, President, CEO and Director, Scottie Resources Corp.

Bradley Rourke
President, CEO and Director | Scottie Resources Corp.
905 - 1111 West Hastings Street, V6E 2J3 Vancouver (CAN)

info@scottieresources.com

+1 250-877-9902

Interview Scottie Resources: Exciting Story in the Golden Triangle


Jerre Foo, Corporate Development Executive, Silkroad Nickel

Jerre Foo
Corporate Development Executive | Silkroad Nickel
50 Armenian Street #03-04, 179938 Singapore (SGP)

enquiries@silkroadnickel.com

+65 6327 8971

Silkroad Nickel: 'The course is set for dynamic profit growth.'


20. April 2021 | 09:45 CET

Varta, Sierra Growth, CureVac - Clear signals!

  • Investments
Photo credits: pixabay.com

Sometimes, for various reasons, it takes longer before the positive developments of a Company are absorbed by the market and thus provide for price gains. It is currently similar to the precious metal gold, which is still in the consolidation phase. The facts such as national debt, inflation fears and the ultra-loose monetary policy of the central banks speak another clear language.

time to read: 3 minutes by Stefan Feulner


 

Author

Stefan Feulner

The native Franconian has more than 20 years of stock exchange experience and a broadly diversified network.
He is passionate about analyzing a wide variety of business models and investigating new trends.

About the author


Sierra Growth - Rocket launch

An interesting story is the newly founded mineral oil exploration Company Sierra Growth, searching for metals silver, copper, gold, and molybdenum. The Canadian Company has focused on exploring projects in the Andean nation of Peru and primarily on three mineral properties in central and western Nevada. The properties are owned by experienced rights holders with a proven track record of exploration in Nevada and all share the same characteristics. Significant preliminary work has been done in the past, but this has generally been limited to surface or near-surface exploration, leaving much exploration potential, particularly at depth. To this end, excellent infrastructure is in place: Power, water, and utilities are available nearby in local mining towns. Because of this, all three properties can be brought to drill-ready status relatively quickly.

The Company announced successful prospect evaluations in the middle of last week. They were so encouraging that management believes that the subsequent phases of exploration will delineate high-quality exploration targets. The package of prospects has excellent potential for the discovery of a significant mineral deposit. Grab samples at the Mildred concession mine area detected 26.6 g/t gold and 78.6 g/t silver and elsewhere detected 667 g/t silver and 0.41 g/t gold. Values of 646 g/t silver and 0.53 g/t gold were also found in the Betty East mine area. Sierra Growth's shares are traded in Frankfurt as well as Toronto. Due to the management experience, the Company can be expected to do well in the long term. However, the development is only at the beginning.

CureVac - Off to Switzerland

CureVac had already started the rolling approval process for the vaccine candidate at the European Medicines Agency (EMA) in February and expects approval for the EU in June, depending on the clinical data. Now, the Tübingen-based German pharmaceutical Company has started a rolling approval process for its Covid-19 vaccine candidate in Switzerland. The marketing authorization application has been submitted to Swissmedic, the drug agency, according to the Company. The rolling review process is an expedited process in which necessary data can be submitted and reviewed as it becomes available to shorten the time to approval.

The duration of the rolling review process depends on the completeness of data submitted by CureVac and the results of the clinical trials, according to Swissmedic.
So far, vaccines from BioNTech, Moderna and Johnson & Johnson have been approved in Switzerland. An application for approval from AstraZeneca is also currently under review by Swissmedic. In early February, the Swiss government had signed a contract with CureVac for the supply of 5 million vaccine doses. This contract is based on the supply agreement between the European Commission and the Company.

Varta - Full in six minutes!

In the past, six minutes was the time it took for a well-poured draft beer. Now the Varta cell 21700 is to be completely charged and discharged in the same time. So far, this would be unique on the market and is expected to significantly impact the Company's sales and profit development in the future. Thus, according to Varta CEO Herbert Schein, the new 21700 cell could add a third business segment. In 2024, Varta plans to produce between 100 and 200 million 21700 battery cells per year. The 21700 battery cell will initially be used primarily in high-performance electric cars. However, the key difference between this and other battery cells on the market is that the 21700 format battery cell, i.e. 2.1 cm in diameter and 7 cm long, will not be used as the sole traction battery. Instead, Varta is aiming to use it as a booster in premium and sports vehicles. Varta's share price does not currently reflect the Company's positive outlook. Further price losses towards EUR 100 could follow a drop below the current support zone at EUR 120.


Author

Stefan Feulner

The native Franconian has more than 20 years of stock exchange experience and a broadly diversified network.
He is passionate about analyzing a wide variety of business models and investigating new trends.

About the author



Conflict of interest & risk note

In accordance with §34b WpHG we would like to point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH may hold long or short positions in the aforementioned companies and that there may therefore be a conflict of interest. Apaton Finance GmbH may have a paid contractual relationship with the company, which is reported on in the context of the Apaton Finance GmbH Internet offer as well as in the social media, on partner sites or in e-mail messages. Further details can be found in our Conflict of Interest & Risk Disclosure.


Related comments:

14. May 2021 | 05:40 CET | by André Will-Laudien

E.ON, Commerzbank, Scottie Resources - Surprisingly good figures!

  • Investments

That was a Father's Day stock market! German holidays are always a popular time for corrections because only half of the otherwise usual market participants are actually involved. The crypto values had to give up a lot after Elon Musk announced on Twitter that he would no longer allow Bitcoins as a means of payment at Tesla in the future, as their extraction is highly negative for the climate. At the same time, he called for the development of a "green coin" that can be obtained with sustainable technologies. Bitcoin lost 12%. In the group of altcoins, there were discounts up to 50%. We take a look at some stocks with special movements.

Read

13. May 2021 | 10:35 CET | by Carsten Mainitz

Steinhoff, Sierra Growth, Vantage Towers - Don't sell in May

  • Investments

Upwards. The shares of the companies mentioned should move in this direction, even in the short term. The wide-ranging menu of opportunities has something for every taste: the still little-noticed "infrastructure stock" Vantage Towers is one of Europe's leading radio mast operators, which analysts still believe has a lot to offer. The permanent restructuring case and penny-stock Steinhoff seems to have finally burst the knot. Speaking of bursting, with new project progress, the exploration Company Sierra Growth could take off virtually overnight.

Read

13. May 2021 | 10:30 CET | by André Will-Laudien

Alibaba, Tencent, Baidu, The Place Holdings: These are the Chinese Doublers!

  • Investments

After weeks of correction in Asian Internet stocks, there are now signs of a revival. On the one hand, the relative valuation to the well-known NASDAQ darlings has decreased significantly. On the other hand, the Chinese benchmark index has already undergone a 20% correction in 2021. Meanwhile, the government has raised its growth forecast to +8.4% in 2021. If we think in terms of post-pandemic categories, when China's major consumer countries pick up steam, Chinese equities should be able to bounce back very quickly.

Read